Opportunity Information: Apply for RFA OD 25 012
This NIH funding opportunity (RFA-OD-25-012) supports one award to continue operating the Informatics, Coordination and Service Center (ICSC) for the Mutant Mouse Resource and Research Centers (MMRRC) consortium. The MMRRC program functions as a national repository and distribution network for mutant mouse strains used in biomedical research, and the ICSC is the hub that makes the consortium work smoothly from an informatics, coordination, and customer-facing service standpoint. The award uses the U42 cooperative agreement mechanism and is explicitly not for clinical trials.
At its core, the ICSC is expected to run and continuously improve the consortium-wide information infrastructure. That includes developing, enhancing, and maintaining the MMRRC in-house data management systems in ways that support modern expectations for data sharing and reuse. A major emphasis is on ensuring MMRRC data can integrate with other animal and non-animal resource databases and align with community standards for accessibility and interoperability. In practical terms, this points to ongoing engineering work around data models, identifiers, metadata standards, system reliability, and interfaces that make it easier for researchers to discover, interpret, and connect MMRRC strain information with related resources.
The opportunity also places heavy weight on service operations that directly affect investigators who donate strains to the MMRRC and those who order strains for research. The ICSC must maintain and further develop a public-facing website portal, operate a Customer Service Center, and run the order processing system. It is responsible for reviewing and processing applications from investigators who want to donate mouse strains, coordinating donation requests across the participating MMRRC sites, and facilitating interactions with biomedical researchers who need help navigating ordering, strain selection, or associated informatics questions. Beyond day-to-day transactions, the ICSC also serves as the consortiums institutional memory by maintaining an archive of MMRRC documents and files, which supports continuity, reporting, and program oversight.
Consortium coordination is another central requirement. The ICSC is expected to host and actively participate in recurring governance and communication activities, including a monthly teleconference and an annual consortium meeting. It must also produce reports and summaries from these meetings when requested by MMRRC members or NIH staff. This coordinating role extends to program visibility and accountability: the ICSC oversees marketing efforts for the consortium and completes routine performance reporting, including monthly and annual metrics. Taken together, these responsibilities make the ICSC both an operational command center and the main interface between the MMRRC network and the broader biomedical research community.
A distinctive feature of this NOFO is its explicit requirement for close coordination with efforts to develop and use new approach methodologies (NAMs) that complement traditional animal-based research. The announcement highlights NAM examples such as cell culture systems, organoids, computational models, and microphysiological systems. Rather than treating NAMs as separate from the MMRRC mission, the ICSC is expected to support activities that collect and analyze comparative information about how NAMs can enhance the predictive power of human disease models and how they can be integrated alongside traditional mouse models. This signals an expectation that the ICSC will help the community navigate when and how different model systems (animal and non-animal) can be used together, and to organize information in ways that make those comparisons findable and usable.
Eligibility is broad across U.S.-based organizational types, including state and local governments, public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses), and other domestic entities that meet NIH requirements. At the same time, the opportunity is clear that non-U.S. entities cannot apply, non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed under NIH policy for this program.
Key administrative details included in the notice are that it is a discretionary grant program administered by the National Institutes of Health, falls under CFDA 93.351, and has an original application due date of May 1, 2026. NIH anticipates making one award. The award ceiling is not listed in the provided summary, suggesting applicants need to consult the full NOFO for budget expectations, project period details, and cooperative agreement terms that typically describe NIH involvement and coordination expectations under a U42 mechanism.Apply for RFA OD 25 012
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Informatics, Coordination and Service Center for the Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.351.
- This funding opportunity was created on 2025-12-05.
- Applicants must submit their applications by 2026-05-01. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This NIH funding opportunity is RFA-OD-25-012. It supports continued operation of the Informatics, Coordination and Service Center (ICSC) for the Mutant Mouse Resource and Research Centers (MMRRC) consortium.
How many awards does NIH expect to make?
NIH anticipates making one award.
What is the MMRRC program?
The Mutant Mouse Resource and Research Centers (MMRRC) program functions as a national repository and distribution network for mutant mouse strains used in biomedical research.
What is the ICSC and why is it important?
The Informatics, Coordination and Service Center (ICSC) is the hub that enables the MMRRC consortium to operate smoothly. It provides consortium-wide informatics infrastructure, coordination functions, and customer-facing services that support both strain donors and strain requestors.
What grant mechanism is used?
The award uses a U42 cooperative agreement mechanism.
Are clinical trials allowed under this opportunity?
No. The opportunity is explicitly not for clinical trials.
What are the core informatics responsibilities of the ICSC?
The ICSC is expected to run and continuously improve the consortium-wide information infrastructure. This includes developing, enhancing, and maintaining MMRRC in-house data management systems in ways that support modern expectations for data sharing and reuse.
What kinds of data-sharing and interoperability goals are emphasized?
A major emphasis is ensuring MMRRC data can integrate with other animal and non-animal resource databases and align with community standards for accessibility and interoperability. Practical areas implied include work on data models, identifiers, metadata standards, system reliability, and interfaces that help researchers discover, interpret, and connect strain information to related resources.
Does the ICSC have responsibilities related to a public website?
Yes. The ICSC must maintain and further develop a public-facing website portal for the consortium.
What service operations must the ICSC provide to the research community?
The ICSC is responsible for service operations that affect both investigators who donate strains and those who order strains. These operations include running a Customer Service Center and operating the order processing system.
What is the ICSC role in processing strain donations?
The ICSC reviews and processes applications from investigators who want to donate mouse strains, coordinates donation requests across participating MMRRC sites, and facilitates related interactions.
What support does the ICSC provide to investigators who want to order strains?
The ICSC supports researchers by helping with ordering, strain selection, and associated informatics questions, and by running the order processing system used for transactions.
What does it mean that the ICSC is the consortium's "institutional memory"?
The ICSC maintains an archive of MMRRC documents and files. This supports continuity across the consortium as well as reporting and program oversight.
What consortium coordination activities are required?
The ICSC is expected to host and actively participate in recurring governance and communication activities, including a monthly teleconference and an annual consortium meeting.
Are meeting reports and summaries required?
The ICSC must produce reports and summaries from consortium meetings when requested by MMRRC members or NIH staff.
Is marketing or outreach part of the ICSC scope?
Yes. The ICSC oversees marketing efforts for the consortium as part of supporting program visibility and accountability.
What performance reporting is expected?
The ICSC completes routine performance reporting, including monthly and annual metrics.
How does this opportunity address New Approach Methodologies (NAMs)?
The NOFO explicitly requires close coordination with efforts to develop and use New Approach Methodologies (NAMs) that complement traditional animal-based research. Examples mentioned include cell culture systems, organoids, computational models, and microphysiological systems.
What is the ICSC expected to do related to NAMs and comparative model information?
The ICSC is expected to support activities that collect and analyze comparative information on how NAMs can enhance the predictive power of human disease models and how NAMs can be integrated alongside traditional mouse models. The emphasis is on organizing information so comparisons across model systems are findable and usable.
Who is eligible to apply?
Eligibility is broad across U.S.-based organizational types, including state and local governments, public and private institutions of higher education, nonprofits (with or without 501(c)(3) status), for-profit organizations (including small businesses), and other domestic entities that meet NIH requirements.
Are non-U.S. organizations eligible?
No. Non-U.S. entities cannot apply.
Can a U.S. organization include a non-U.S. component or foreign component?
No. Non-U.S. components of U.S. organizations are not eligible, and foreign components are not allowed under NIH policy for this program.
What agency is administering this grant program?
This is a discretionary grant program administered by the National Institutes of Health (NIH).
What is the CFDA number associated with this opportunity?
The CFDA number listed is 93.351.
What is the application due date?
The original application due date is May 1, 2026.
Is there an award ceiling listed in the provided summary?
No. The award ceiling is not listed in the provided summary. Applicants are expected to consult the full NOFO for budget expectations, project period details, and the cooperative agreement terms that describe NIH involvement and coordination expectations under the U42 mechanism.
Where should applicants look for details not included in this summary?
Applicants should consult the full NOFO for budget guidance, project period information, and the specific cooperative agreement terms (including the nature of NIH involvement) that apply to a U42 award.
Browse more opportunities from the same category: Health
Previous opportunity: Cooperative Agreement for affiliated Partner with the Rocky Mountain Cooperative Ecosystem Studies Unit (CESU)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA OD 25 012
Applicants also applied for:
Applicants who have applied for this opportunity (RFA OD 25 012) also looked into and applied for these:
| Funding Opportunity |
|---|
| Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed) Apply for RFA OD 25 011 Funding Number: RFA OD 25 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed) Apply for RFA OD 25 010 Funding Number: RFA OD 25 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) Apply for PAR 26 116 Funding Number: PAR 26 116 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| NIGMS Institutional Biomedical Undergraduate Research Training (BURT) Program (T34) Apply for PAR 26 033 Funding Number: PAR 26 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional) Apply for PAR 26 121 Funding Number: PAR 26 121 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) Apply for PA 26 001 Funding Number: PA 26 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Extension of the World Trade Center Health Registry (U50) Apply for RFA OH 26 016 Funding Number: RFA OH 26 016 Agency: Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $9,480,000 |
| Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Apply for PAR 25 444 Funding Number: PAR 25 444 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) Apply for RFA CA 25 032 Funding Number: RFA CA 25 032 Agency: National Institutes of Health Category: Health Funding Amount: $1,240,000 |
| Engineering Improved Stem Cell-Derived Islet Cells for Replacement Therapies (R01 - Clinical Trial Not Allowed) Apply for RFA DK 26 306 Funding Number: RFA DK 26 306 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Drug-Free Communities (DFC) Support Program - New (Year 1 Recompete) Apply for CDC RFA CE 26 0220 Funding Number: CDC RFA CE 26 0220 Agency: Centers for Disease Control - NCIPC Category: Health Funding Amount: $125,000 |
| Drug-Free Communities (DFC) Support Program - (Year 6 - FY25 Cohort) Apply for CDC RFA CE 26 0208 Funding Number: CDC RFA CE 26 0208 Agency: Centers for Disease Control - NCIPC Category: Health Funding Amount: $125,000 |
| Fiscal Year (FY) 2026 National Technical Assistance Programs (NTAP) Cooperative Agreements Apply for HRSA 26 009 Funding Number: HRSA 26 009 Agency: Health Resources and Services Administration Category: Health Funding Amount: $8,000,000 |
| Single Source: Outcomes of Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Required) Apply for RFA HG 26 008 Funding Number: RFA HG 26 008 Agency: National Institutes of Health Category: Health Funding Amount: $687,000 |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 26 017 Funding Number: RFA RM 26 017 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional) Apply for PA 26 002 Funding Number: PA 26 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| FY2026 Cooperative Agreement for 988 Suicide & Crisis Lifeline Administrator Apply for FG 26 001 Funding Number: FG 26 001 Agency: Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $231,482,876 |
| Service Area Competition - Additional Area 1 Apply for HRSA 26 007 Funding Number: HRSA 26 007 Agency: Health Resources and Services Administration Category: Health Funding Amount: $1,565,269 |
| The NINDS Human Biospecimen and Data Repository (U24 - Clinical Trial Not Allowed) Apply for RFA NS 26 010 Funding Number: RFA NS 26 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) Apply for RFA NS 27 001 Funding Number: RFA NS 27 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA OD 25 012", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
